China’s Jilin Zixin Pharmaceutical Industrial has splashed out $42 million to buy a Rhode Island-based high-definition genome mapping company, Nabsys 2.0.
Osaka-based Takeda Pharmaceutical is reviewing prospects to sell a majority stake in Wako Pure Chemical.
Management has offered to buy Beijing-based radiotherapy and diagnostic firm Concord Medical Services in a $228 million bid.
Hanmi Pharmaceutical eyes branded drugs, fast-paced R&D and investment in China to get growth on track.
Nichi-Iko Pharmaceutical will buy Sagent Pharmaceuticals in a $736 million all-cash deal with management and boards from both side agreeing to terms aimed at…
A rush by Chinese companies to buy healthcare-related assets abroad is in full swing, although risks in running the operations need to be considered.
Taisho Pharmaceutical has bought a 24.5% stake in Vietnam's DHG Pharmaceutical, the country's top drug distributor.
Aurobindo Pharma wants to snap up some of the generics up for grabs from Teva Pharmaceutical Industries as it sells products to meet antitrust concerns so it…
Astellas Pharma and Shionogi are looking to sell branded drugs that have expired patents in Japan in a play to take the funds and invest in newer therapies or…
Takeda Pharmaceutical has reached an agreement with Altos Therapeutics for the development and commercialization rights to gastroparesis candidate ATC-1906.